| 0 (0%) | 01-19 18:52 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.7 |
1-year : | 11.33 |
| Resists | First : | 8.31 |
Second : | 9.7 |
| Pivot price | 6.86 |
|||
| Supports | First : | 6.93 |
Second : | 6.09 |
| MAs | MA(5) : | 7.06 |
MA(20) : | 6.93 |
| MA(100) : | 6.69 |
MA(250) : | 7.57  |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 77 |
D(3) : | 69 |
| RSI | RSI(14): 58.4 |
|||
| 52-week | High : | 11.98 | Low : | 5.59 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CSBR ] has closed below upper band by 8.4%. Bollinger Bands are 23.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.3 - 7.33 | 7.33 - 7.36 |
| Low: | 7.01 - 7.05 | 7.05 - 7.09 |
| Close: | 7.14 - 7.21 | 7.21 - 7.27 |
Sat, 17 Jan 2026
How Champions Oncology Inc. (CSBR) Affects Rotational Strategy Timing - Stock Traders Daily
Sat, 17 Jan 2026
Is Champions Oncology, Inc.'s (NASDAQ:CSBR) Latest Stock Performance A Reflection Of Its Financial Health? - Yahoo Finance
Fri, 09 Jan 2026
Analyst Calls: Will CSBR stock outperform Nasdaq index - Trade Exit Summary & Entry Point Strategy Guides - Bộ Nội Vụ
Thu, 08 Jan 2026
Will CSBR stock outperform Nasdaq index - 2025 Earnings Impact & Weekly Return Optimization Alerts - Улправда
Thu, 08 Jan 2026
Champions Oncology (CSBR) Earnings Transcript - AOL.com
Wed, 07 Jan 2026
Champions Oncology (CSBR) Earnings Transcript - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 14 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 26.6 (%) |
| Held by Institutions | 47.2 (%) |
| Shares Short | 81 (K) |
| Shares Short P.Month | 79 (K) |
| EPS | 0.17 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.3 |
| Profit Margin | 4.2 % |
| Operating Margin | 1.2 % |
| Return on Assets (ttm) | 5.5 % |
| Return on Equity (ttm) | 98.9 % |
| Qtrly Rev. Growth | 11.5 % |
| Gross Profit (p.s.) | 2.1 |
| Sales Per Share | 4.2 |
| EBITDA (p.s.) | 0.28 |
| Qtrly Earnings Growth | -61.1 % |
| Operating Cash Flow | 6 (M) |
| Levered Free Cash Flow | 5 (M) |
| PE Ratio | 42.41 |
| PEG Ratio | 0 |
| Price to Book value | 24.03 |
| Price to Sales | 1.71 |
| Price to Cash Flow | 16.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|